Biotechnology in Japan

Biocom Systems, Inc

We can support R&D of transdermal and topical drug delivery and also evaluate percutaneous absorption of chemical compounds. We develop SKIN-CAD®, simulation software for skin pharmacokinetics of transdermal and topical drug delivery. SKIN-CAD® predicts the time courses of skin permeation, skin distribution and blood concentration under various modes of transdermal and topical delivery based on a combined model of skin diffusion layers and body compartments.

1 to 10 staff

Cytix Inc

7F Terada Bldg, 2-3-3 Shibakoen, Minato-ku, Tokyo, 105-011 JAPAN

11 to 50 staff

Morinaga Bioscience, Inc

Morinaga Institute of Biological Science, Inc.(MIoBS) is a member of Morinaga & Co, Ltd.(Morinaga group). We are focusing on developing the reagents for food safety and laboratory animals, utilizing immunoassay techniques as ELISA, Western blotting and Lateral Flow device. We are also responsible for analysis for food safety, quality control and hygiene assurance in Morinaga group. As a result of the recent increase in global interest in food allergies, regulations about the labeling of foods that contain allergens have been coming into effect in Japan since April 2001. Twenty-seven items3) have been designated for labeling and the Food Sanitation Act mandates that seven of those items (eggs, milk, wheat, buckwheat, peanut, shrimp, and crab) be listed in the ingredients. We used our exclusive immunoassay technology to begin selling ELISA kits for allergen testing (5 items) before the rest of the world in April 2002, and the kits were designated as official testing methods by the Japanese Ministry of Health, Labor, and Welfare in November of the same year. In 2005, we began selling FASPEK allergen testing kits that allow users to measure quantities in processed foods using an extract developed exclusively by MIoBS. That same year, the kits were designated as validated and accurate test kits by the Ministry of Health, Labor, and Welfare, and many Japanese public testing agencies, analysis agencies, and food companies use them to this day. Then, recognizing the sophistication of the technology, the Food and Drug Administration (FDA) designated the wheat kit5) as the official testing method for gluten-free foods.

51 to 200 staff

Nacalai Tesque, Inc

Nacalai Tesque is one of the leading life science reagent suppliers in Japan. Nacalai Tesque is a Manufacturer of HPLC and capillary columns, toxins, antibodies, enzymes, cell culture media, analytical kits, fine chemicals and research chemicals. Supplier to laboratories at universities, pharmaceutical and food-beverage companies, public and private research institutes, and to other Japanese trading houses. Importer / Distributor of products from the leading biochemical and life science companies. Exporter of its own COSMOSILR HPLC and capillary columns, separation kits, toxins, bio- reagents and fine chemicals. Recognized in the international research chemical and life science market Nacalai Tesque gears up its R&D and business activities for meeting the global demand in Biotechnology, Genomics, Proteomics, and Nanotechnology.

201 to 500 staff

Matrixome

Matrixome” is a novel term proposed by Professor Kiyotoshi Sekiguchi, at Osaka University. The term ‘matrixome’ is a subset of the proteome to define whole collections of extracellular matrix molecules that constitute the customized microenvironments of individual cell types. Under this concept, Matrixome, Inc. was established to conduct research on the matrixome and its applications.

11 to 50 staff

Iwai Chemicals Company Ltd

1 to 10 staff

On-Chip Biotechnologies Co., Ltd

On-chip® Sort On-chip® Droplet Generator On-chip® Droplet Selector On-chip® SPiS

11 to 50 staff

Liconic Japan

1 to 10 staff

Legacy Healthcare

Legacy Healthcare is a Swiss-based biopharmaceutical company focused on leveraging the pleiotropic activity and strong safety profile of plants to develop prescription botanical drugs that address serious medical conditions. Our first product candidate, CINAINU, has demonstrated strong safety and efficacy in patients suffering from alopecia areata, a chronic autoimmune condition with highly damaging psycho-social issues that impact all who suffer from it, especially children.

11 to 50 staff

Genefrontier Corp

11 to 50 staff

Institute For Advanced Biosciences, Keio University

We use cutting-edge biotechnologies to comprehensively measure and analyze human and micro-organic cellular activity, conduct computer analysis and simulation, and apply findings to medical, environmental, and food sciences. IAB is attracting attention from around the world as a pioneer in the new life sciences field that makes full use of IT in this way called Integrated Systems Biology.

11 to 50 staff

Photoq3 Inc

Biopharmaceuticals, including antibody drugs, have shown significant therapeutic effects, but they are not perfect. In addition, as the world’s super-aging society advances, there is an ever-increasing demand for treatments that are less burdensome on the body and preserve function. Based on our many years of experience and knowledge in the development of antibody drugs and phototherapy, we have searched for a treatment method that is less burdensome on the body and preserves function. As a result, we sucessfully established iTAP (intelligent Targeted Antibody Phototherapy) method. The iTAP method combines physical energy (light), biospecific binding (antibodies, peptides, etc.), and toxins to create a synergistic effect, and also makes it possible to control the extent of treatment and minimize side effects. PhotoQ3 was established in 2019 with the goal of “shedding new light on a world without a cure” based on the iTAP method, and is currently working to commercialize it as a new cancer treatment. The Company also possesses fundamental technologies such as protein expression technology and target discovery and quantification technology by proteogenomics, and aims to promote research and development not only in novel cancer drugs, but also in a wide range of other areas. To this end, we intend to actively promote collaboration with universities, medical institutions, research institutes, and other organizations, as well as joint relationships with pharmaceutical companies. We intend to continue our efforts to provide more optimal and advanced treatments for intractable diseases, especially cancer, and to realize medical care that enhances the quality of life, by making full use of our proprietary fundamental technologies.

1 to 10 staff

Takara Bio Inc

19791988PCRCDMO(Contract Development and Manufacturing Organization) Smiles in Life ※ X https://note.takara-bio.co.jp/x.com/Takara_Bio_JP Since 1979, Takara Bio has supported global life science research by providing innovative products and services. We were the first company to market genetic engineering research reagent (restriction enzyme) in Japan in 1979 and to introduce PCR system in 1988. Today, we offer approximately products for genetic and cell engineering research and provide high-quality, high-value-added genetic analysis services using Japan’s largest next-generation sequencers. We also serve as a CDMO (Contract Development and Manufacturing Organization) in regenerative medicine, cell therapy, and gene therapy fields, supporting pharmaceutical companies and biotech ventures worldwide. Takara Bio aims to bring “Smiles in Life” through biotechnology. This account focuses on product and service updates rather than recruitment information. Official X account (Japanese) https://note.takara-bio.co.jp/x.com/Takara_Bio_JP Global Network: Takara Bio Engineering (Dalian) Co, Ltd. Takara Korea Biomedical Inc. Takara Bio Medical Technology (Beijing) Co, Ltd. DSS Takara Bio India Pvt Ltd Takara Bio USA, Inc. Takara Bio Europe

1001 to 5000 staff

Phcbi Global

PHCbi Laboratory and Medical equipment is designed to meet the demands of the life science industries providing reliability, accuracy and usability of preservation, incubation and sterilization to facilitate cutting-edge research."PHCbi" is a new brand for our Life Science business that has globally supported research and healthcare over 50 years under previous brands. Since 1966, when we first launched pharmaceutical refrigerators in Japan, aiming to support advanced research in Life Science field, we have provided equipment and services required for sample preservation and bacterial / cell culture as well as maintenance of clean room environment. Our long history of manufacturing, sales, support and service excellence has earned us the respect of our customers throughout the world. We apply strict quality management in our global manufacturing system including the core manufacturing sites in Japan.

5001 to 10000 staff

In Silico Biology, Inc

ISB, in silico biology,inc, provides the series of software products which make it possible to simultaneously browse genome annotation, the analysis results of the large-scale tiling array and the next generation sequencer data, across the large genome sequence. These software products are already used in hundreds of the domestic universities and at the research institutes. These kinds of software technology are still rarely introduced in worldwide basis. Through the joint research with Nara Institute of Science and Technology and National Institute of Advanced Industrial Science and Technology and so on, ISB constantly implements such new generation technology and provides molecular biologists with the comprehensive analytical software tools.

1 to 10 staff

Syntheticgestalt

We are developing machine learning models for drug discovery and software for facilitating and automating research in the life-sciences industry.

11 to 50 staff

Nexuspiral Inc

1 to 10 staff

株式会社協和

No.1fracora

51 to 200 staff

Integriculture Inc.(インテグリカルチャー株式会社)

Integriculture Inc, a cellular agriculture platform company, develops sustainable protein, namely cell-based meat, and offers its production capability and technology to variety of clients wanting to develop products involving cell culture. Cell-based meat carries high hope as the holy grail to sustainable protein, for which $2T market is at stake. However, the production cost has been prohibitively high. Our patented “CulNet System” cultures cells 4~5 orders of magnitude less expensive to enable us to market cell-based meat at competitive prices. The system requires no externally added growth factors or serum, making it cleaner and safer compared to conventional meat, and even products by other cellular agriculture companies. The system in principle cultures any cells and produce anything produced by living things. Its astounding versatility makes it ideal for a general platform for clients wanting to produce food, cosmetics, supplements, functional ingredients, pharmaceuticals, and any other biological and agricultural products.

11 to 50 staff

セルソース株式会社

51 to 200 staff